| Erselius, Jörn R. (Max Planck Innovation Managing Director before Garching Innovation 200311) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
| Erwin, M. Johnston (Eli Lilly 201603 VP Corporate Business Development) |
Business Development Manager / Strategy Manager |
Eli Lilly (Group) |
United States (USA) |
| Eschenfelder, Christina (Rittershaus 201511 Lawyer) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
| Escher, Adrian (ESBATech 200205 CFO) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
| Escher, Dominik (Belleveue 201001 Managing Partner at BB Pureos Bioventures before ESBATech CEO + Founder) |
Managing Partner |
Bellevue (Group) |
United Kingdom (GB) |
| Escher, Klaus |
n. a. |
BASF (Group) |
Germany |
| Esper, Ralph (Eppendorf 201811– Head of Corporate Communications before Hagebau + Hamburger Sparkasse) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
| Esposito, Gloria (Artemis 200705– Project Manager) |
n. a. |
Taconic (Group) |
Germany |
| Essenpreis, Matthias (Roche 201502 CTO of Roche Diagnostics) |
Chief Technology/Technical Officer (CTO) |
Roche (Group) |
United States (USA) |
| Essig, Stuart M. (Wellington Partners 201303– Venture Partner before Integra Life Sciences CEO + Goldman Sachs) |
Venture Partner |
Wellington Partners (Group) |
Germany |
| Essinger, Jacques R. (Symetis 201703 CEO) |
Chief Executive Officer (CEO) |
Boston Scientific (Group) |
Switzerland |
| Esslinger, Christoph (Memo Therapeutics AG 202011 CSO + Co-Founder formerly CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Memo Therapeutics AG |
Switzerland |
| Etches, Robert J. (Rob) (Crystal Bioscience 201401 CEO) |
Chief Executive Officer (CEO) |
Crystal Bioscience Inc. |
United States (USA) |
| Ettenberg, Seth (Bayer 202003– CSO BlueRock Therapeutics before Unum Therapeutics + Novartis IBR + CuraGen) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bayer (Group) |
United States (USA) |
| Etzold, Thure (Lion Bioscience 200502–200604 CEO resigned) |
Chief Executive Officer (CEO) |
Expedeon (Group) |
Germany |
| Eugster, Rudolf (Tecan 200212–20203 CFO RETIRED 3/20) |
Chief Financial Officer (CFO) |
Tecan (Group) |
Switzerland |
| Eul, Wilfried (Evonik 201207 SVP + Head Catalysts Business Line) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
| Euller, Gordon (Apex Ventures 202010 Partner Digital Health) |
Partner (venture partner) |
Apex Ventures (Group) |
Austria |
| Evans, David (Syngenta 200404) |
n. a. |
Syngenta (Group) |
Switzerland |
| Evans, Richard (EKF Diagnostics 201307– COO before Finance Director) |
Chief Operating Officer (COO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Evans, Thomas G. (Tom) (Vaccitech 201908– CSO before CEO before Vical + Novartis + Aeras) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Vaccitech Ltd. |
United Kingdom (GB) |
| Evans-Freke, Stephen (Celtic Therapeutics 2007 General Partner + Co-Founder) |
General Partner (venture partner) |
Auven Therapeutics (Group) |
United States (USA) |
| Evenden, Anja (Vego Ltd 201401 Marketing Executive) |
Sales Manager / Marketing Manager |
Vego Ltd. |
United Kingdom (GB) |
| Evens, Andrew (Tufts University 201601 Prof at Tufts Univ School of Medicine + Director of Cancer Center) |
Professor |
Affimed (Group) |
Germany |
| Everson, Lloyd (MolecularHealth 201401 CEO of US division before US Oncology Inc) |
Chief Executive Officer (CEO) |
Molecular Health (Group) |
United States (USA) |
| Evertsz, Carl J. G. (MeVis Medical Solutions 200609–201202 CEO LEAVES 3/12) |
Chief Executive Officer (CEO) |
Varian Medical Systems (Group) |
Germany |
| Evnin, Luke (MPM Capital 201307 Managing Director) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
| Ewert, Markus L. E. (Alentis Therapeutics 201904–202007 CEO before Ablynx+ GE Healthcare + Novartis + BC LEFT 7/20) |
Chief Executive Officer (CEO) |
Alentis Therapeutics AG |
Switzerland |
| Eyber, Klaus U. (Kaye Scholer 200407– Attorney + Partner at Kay Scholer in Ffm before Haarmann Hemmelrath) |
Attorney / Lawyer |
Arnold & Porter LLP |
Germany |
| Eylenbosch, Hilde (Biocartis 201611–201904 CCO joined 2013 before Alere + SPD Swiss Precision LEFT 5/19) |
Chief Commercial Officer (CCO) |
Biocartis (Group) |
Belgium |
| Ezickson, Elan (Aveo Pharmaceuticals 201112 CBO) |
Chief Business Officer (CBO) |
Aveo Pharmaceuticals Inc. |
United States (USA) |
| Faber, Christian Jörg (Alytas Therapeutics 201808– Managing Director) |
Managing Director |
Alytas Therapeutics GmbH |
Germany |
| Fáber, René (Sartorius 202010 Head of Bioprocess Solutions Division) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Fabro, Scott (Evolva 20107– CCO before Sweet Harvest Foods + ACH Foods + Kerry + Cargill) |
Chief Commercial Officer (CCO) |
Evolva (Group) |
Switzerland |
| Fackler, Thomas |
n. a. |
Fraunhofer (Group) |
Germany |
| Faeh, Urban (Bruker 201001– President Bruker Optics division joined Bruker 1998 as sales manager) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
| Fafflock, Heike (Bremen 201005– Innovation Manager Health before B.I.T. + hkk) |
n. a. |
Bremen (govt region) |
Germany |
| Fagan, Maria (Regulatory and Quality Solutions 202009 President + Co-Founder) |
Chief Executive Officer (CEO) |
Regulatory and Quality Solutions (R&G) (Group) |
United States (USA) |
| Fagerberg, Jan (Micromet 200911 SVP + CMO) |
Chief Medical Officer (CMO) |
Amgen (Group) |
Germany |
| Fahr, Anne-Marie (Labor Limbach 200909 Head Microbiology) |
Laboratory Manager (industry) |
Labor Limbach (Group) |
Germany |
| Fahrenberg, Jens (Karlsruhe Institute of Technology 201307 Head of Innovation Management Office) |
IP Manager |
Karlsruhe Institute of Technology (KIT) |
Germany |
| Fairey, William (Bill) (MyoKardia 201901– CCO before ChemoCentryx + Actelion + Parke-Davis Pharmaceuticals US) |
President/Director/Head Business Group/Unit/Division |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Fakih, Sarah (CureVac 202007– VP Investor Relations before MorphoSys + Qiagen) |
Public Relations Manager / Investor Relations Manager |
CureVac N.V. (Nasdaq: CVAC) |
Netherlands |
| Falcenberg, Matthias (Forbion 201604– Analyst at Munich Office before at MPI of Biochemistry) |
Analyst (Financial / Industry) |
Forbion Capital Partners (NL) |
Germany |
| Falch, Siegfried (JEOL 201002 Managing Director JEOL (Germany) GmbH) |
Managing Director |
JEOL (Group) |
Germany |
| Falchuk, Jason (BioBridges 201709 President + Founding Partner) |
President/Director/Head Business Group/Unit/Division |
Adecco (Group) |
United States (USA) |
| Falk, Ursula (Dr Falk Pharma 201403 Managing Director) |
Managing Director |
Dr. Falk Pharma (Group) |
Germany |
| Falken, Ulrich (Analyticon Biotechnologies 2007 COO) |
Chief Operating Officer (COO) |
Analyticon Biotechnologies AG |
Germany |
| Fallen, Karen (Lonza 201308 VP Licensing + Technology Lonza Development Services) |
Business Development Manager / Strategy Manager |
Lonza (Group) |
Switzerland |
| Fambrough, Douglas M. (Dicerna Pharmaceuticals 201711 CEO) |
Chief Executive Officer (CEO) |
Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) |
United States (USA) |
| Fang, Peter (Boehringer 202002 SVP + Head of Therapeutic Area Inflammation) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Faraco, Vincenza (University of Naples Federico II 201405) |
Researcher (university / research institute) |
University of Naples Federico II |
Italy |
| Farhangi, Sonja (Stratec 201110 Stratec Molecular GmbH Marketing + Public Relations) |
Sales Manager / Marketing Manager |
Stratec (Group) |
Germany |
| Farid, Ramy (Schrödinger 202011 CEO) |
Chief Executive Officer (CEO) |
Schrödinger (Group) |
United States (USA) |
| Farinelli, Laurent (Fasteris 200901 CEO + co-founder |
Chief Executive Officer (CEO) |
Fasteris S.A. |
Switzerland |
| Farmer, Jeffrey (Brooks Automation 201307 VP + General Manager of Brooks Life Science Systems) |
General Manager (management) |
Brooks Automation (Group) |
United States (USA) |
| Farre, Cecilia (Nanion 201309 Marketing Director) |
Sales Manager / Marketing Manager |
Nanion (Group) |
Germany |
| Farzan, Nima (PaxVax 201507 CEO) |
Chief Executive Officer (CEO) |
PaxVax (Group) |
United States (USA) |
| Fasler, Stephan (Exquiron Biotech AG 201502 CEO) |
Chief Executive Officer (CEO) |
Evotec (Group) |
Switzerland |
| Fastenau, Robin (Metabolon 201409 VP Corporate Marketing + Communications) |
Sales Manager / Marketing Manager |
Metabolon (Group) |
United States (USA) |
| Fath, Andreas (Univ Furtwangen 201411 Professor) |
Professor |
Hochschule Furtwangen University (HFU) |
Germany |
| Fathi, Marc (University Geneva 201008 HUG Toxicology Lab) |
Researcher (university / research institute) |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
| Fatscher, Hans Peter (Qiagen 201710– VP + Head of Qiagen Custom Solutions business) |
President/Director/Head Business Group/Unit/Division |
Qiagen Custom Solutions (business unit) |
|
| Faulstich, Konrad (201011 Director Strategic Alliances before ESE GmbH 200909 Head BusDev) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Faure, Alexia (NewCap 201705– Consultant before Hume Brophy since 201409) |
Public Relations Manager / Investor Relations Manager |
NewCap. – Investor Relations & Financial Communications |
France |
| Faus, Ignacio (Mologen 201808–201903 CEO former CEO + Co-Founder of Palau Pharma LEFT EARLY 3/19) |
Chief Executive Officer (CEO) |
Mologen (Group) |
Germany |
| Faust, Nicole (Cevec 201904 CEO + CSO joined Cevec 201105 before amaxa + Artemis Pharmaceuticals) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Cevec (Group) |
Germany |
| Fayolle, Ambroise (EU (govt) 201607 VP of EIB) |
n. a. |
EU (govt) |
Luxembourg |
| Federer, Werner (V&F 201103 President) |
President/Director/Head Business Group/Unit/Division |
V&F (Group) |
Austria |
| Fedunik, Olivia (Prefound GmbH 201501 Managing Director) |
Managing Director |
Prefound GmbH |
Germany |
| Feger, Dieter (MorphoSys 200901 Head AbD Serotec business before Abbott Diagnostics Marketing Director Global Marketing) |
General Manager (management) |
Bio-Rad (Group) |
Germany |
| Fehmer, Jürgen (Geneworx AG) |
n. a. |
Geneworx AG |
Germany |
| Fei, Dr. (Techpool Bio-Pharma 1993– Founder + CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
China |
| Feig, Francois (Merck Serono 200706 Head Global Therapeutic Area Endocrinology + Cardio-Metabolic Care) |
endocrine/metabolic disease |
Merck (DE) (Group) |
Germany |
| Feige, Michael (Methrom 201301– Managing Director of Deutsche Methrom Prozessanalytik GmbH & Co KG) |
Managing Director |
Metrohm (Group) |
Germany |
| Feingold, Jay (ADC Therapeutics 201902 CMO + SVP Clinical Development) |
Chief Medical Officer (CMO) |
ADC Therapeutics (Group) |
Switzerland |
| Feist, Frank (BlueCatBio 201411– CEO + Founder before NobleGen Biosciences + BC + Olympus America + Polytechnos) |
Chief Executive Officer (CEO) |
BlueCatBio (BCB) (Group) |
United States (USA) |
| Felber, Erich (Biovertis 200409– CEO before Micromet) |
Chief Executive Officer (CEO) |
Deinove (Group) |
Austria |
| Felciano, Ramon (Ingenuity Systems 200705 Chief Technology Officer) |
n. a. |
Qiagen (Group) |
United States (USA) |
| Feldsine, Phil (BioControl Systems 201701 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Felgenhauer, Thomas (Pepperprint GmbH 2011– Head RnD before DKFZ) |
Research & Development Manager |
Pepperprint GmbH |
Germany |
| Feling, Nicole (Köhl et Feling 201310 Partner + Bicoll PR) |
Public Relations Manager / Investor Relations Manager |
Innovation Industries (NL) |
Germany |
| Fellenberg, Friederike (NCT Heidelberg 201810 Press + Public Relations) |
Public Relations Manager / Investor Relations Manager |
National Center for Tumor Diseases (NCT) Heidelberg (Nationales Centrum für Tumorerkrankungen) |
Germany |
| Feller, Christine |
n. a. |
Baden-Württembergische Bank AG |
|
| Fellner, Peter (Acambis 200703 President) |
Board member, non-executive |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Felzmann, Thomas (AOP Orphan 201110 Managing Director + Founder of Activartis Biotech GmbH) |
Managing Director |
Élan (Group) |
Austria |
| Fenge, Christel (Sartorius 201201 VP Fermentation Technologies at Sartorius Stedim Biotech) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Fenzl, Edgar J. (FGK Clinical Research 201411 Managing Director + Co-founder) |
Managing Director |
FGK Clinical Research GmbH |
Germany |
| Fernández, Javier (Vitro SA 201805 CEO) |
Chief Executive Officer (CEO) |
Vitro (ES) (Group) |
Spain (España) |
| Fernández-Alba, Amadeo Rodriguez (Univ Almería 201311 Prof + EURL-FV) |
Professor |
University of Almería (Universidad de Almería) |
Spain (España) |
| Ferneding, Stephan (Accurion GmbH 201602 Managing Director) |
Managing Director |
Accurion (Group) |
Germany |
| Ferreira, Isabel (Versameb 201910c– CBO before Roche Partnering + Prosensa) |
Chief Business Officer (CBO) |
Versameb AG |
Switzerland |
| Fert, Vincent (HalioDx 201503– CEO + CO-founder before Ipsogen 200708– President + CEO) |
Chief Executive Officer (CEO) |
HalioDx S.A.S. |
France |
| Fertig, Niels (Nanion Technologies GmbH 201102 Managing Director CEO) |
Managing Director |
Nanion (Group) |
Germany |
| Fesik, Stephen W. (Vanderbilt Univ 200905– Professor before Abbott divisonal VP Cancer Research) |
Professor |
Abbott (Group) |
United States (USA) |
| Fesseler, Jana (BioRegio STERN 201802–) |
Cluster Manager |
BioRegio STERN Management GmbH |
Germany |
| Fest, Constantin (Merck (DE) 201301– Head Investor Relations joined 6/12 before Lanxess) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| Festel, Gunter (Festel Capital 200501) |
n. a. |
Festel Capital |
Switzerland |
| Feuerstein, Marco (microDimensions GmbH 2011– Managing Director (COO) + Co-founder) |
Managing Director |
microDimensions GmbH |
Germany |
| Feuillet, Catherine (Bayer 201401 Head of Trait Research at Bayer CropScience) |
Researcher (industry) |
Bayer (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 16 17 18 ... 72 73 74 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
